Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | CLPP | Q16740 | 3/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 8/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | CACNA1G | O43497 | 1/20 | 0.38 |
| ▸ | CACNA1H | O95180 | 1/20 | 0.38 |
| ▸ | CACNA1I | Q9P0X4 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.37 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.36 |
| ▸ | ITGA5 | P08648 | 1/20 | 0.36 |
| ▸ | TCF4 | P15884 | 1/20 | 0.36 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.36 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL745891 | 1.00 | ALDH1A1 (0.43) | ALDH1A1CLPPCYP3A4SMN1; SMN2CACNA1G | |
| SCHEMBL747399 | 0.94 | ALDH1A1 (0.42) | ALDH1A1CLPPCYP3A4KMT2A | |
| SCHEMBL747276 | 0.93 | ALDH1A1 (0.49) | ALDH1A1CLPPCYP3A4SMN1; SMN2CACNA1G | |
| SCHEMBL749509 | 0.93 | CYP3A4 (0.43) | ALDH1A1CLPPCYP3A4CACNA1GCACNA1H | |
| SCHEMBL744820 | 0.92 | ALDH1A1 (0.39) | ALDH1A1CLPPCYP3A4SMN1; SMN2CACNA1G | |
| SCHEMBL746041 | 0.92 | ALDH1A1 (0.38) | ALDH1A1CLPPCYP3A4SMN1; SMN2CACNA1G | |
| SCHEMBL12036390 | 0.90 | CLPP (0.41) | ALDH1A1CLPPCYP3A4 | |
| SCHEMBL744660 | 0.90 | CACNA1G (0.46) | CLPPCYP3A4CACNA1GCACNA1HCACNA1I | |
| SCHEMBL14629508 | 0.89 | ALDH1A1 (0.44) | ALDH1A1CLPPCYP3A4CACNA1GCACNA1H | |
| SCHEMBL744761 | 0.89 | CYP3A4 (0.44) | ALDH1A1CLPPCYP3A4CACNA1GCACNA1H |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090215783-A1 | COMPOSITION FOR INDUCTION OR INHIBITION OF STEM CELL DIFFERENTIATION | CHOONGWAE PHARMA CORPORATION (KR) | 2009-08-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090215783-A1 | COMPOSITION FOR INDUCTION OR INHIBITION OF STEM CELL DIFFERENTIATION | MYLK2, TNNC1, MYH2 | ALDH1A1 648/4885CLPP 3986/4885CYP3A4 4483/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.